Lobbying Filing Details

Total Spending

$770,000

Activities

1

Lobbyists

3

Gov't Entities

2

Filing Information
Filing UUID:
53a65708-4283-43a1-9ed5-ca51b9d94fa7
Type:
Q4 - 4th Quarter - Report
Period:
2023 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 19, 2024 at 6:14 PM
Income:
$0
Expenses:
$770,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: G. Joel Baise, Director, Government Relations
Registrant
WALGREEN COMPANY

Retail Pharmacy

WASHINGTON, District of Columbia
Client
WALGREEN COMPANY
District of Columbia, United States of America
Lobbying Activities (1)
Activity 1
Pharmacy

H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.

Lobbyists (3)
  • KATIE L SMITH
  • MRS. MADELINE KAY HODGE
  • ISAAC FORDJOUR
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.